TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06120205

Intervention type: DEVICE
Group type: OTHER
Intervention: Teal Wand Self-Collection Device Group
Description: Participants will use the Instructions for Use to perform self-collection of vaginal cells and material using the Teal Wand Self-Collection Device, and will fill out a usability survey and a satisfaction and needs survey. A healthcare provider collected sample will be performed by a clinician after self-collection. The patient will serve as their own comparator/control.
Study: NCT05201586

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conditional Cash Transfer
Description: CCTs will be given to participants in the form of a pre-loaded debit card.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Semi-structured interviews
Description: Research team will conduct semi-structured interviews exploring how social determinants of health and social needs impact health. Participants will be asked to set a health goal. 6 months after the initial interview, the team will interview the patients again and evaluate whether that health goal was achieved.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Semi-structured interviews
Description: Research team will conduct semi-structured interviews exploring how social determinants of health and social needs impact health. Participants will be asked to set a health goal. 6 months after the initial interview, the team will interview the patients again and evaluate whether that health goal was achieved.
Study: NCT06450821

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PRIOR [Proactive Intensive Oral Review & Treatment]
Description: Intervention Arm: Professional Oral Health Care (POHC) referred to as PRIOR \[Proactive Intensive Oral Review \& Treatment\] prior to chemotherapy.
Study: NCT03834571

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV
Study: NCT06643728

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bimagrumab
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bimagrumab
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC
Study: NCT03834571

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Given IV

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Patient Monitoring
Description: Undergo active monitoring

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiation
Study: NCT06643728

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tirzepatide
Description: Administered SC

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tirzepatide
Description: Administered SC

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC
Study: NCT03834571

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation Therapy
Description: Undergo radiation
Study: NCT05922215

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic Balance training
Description: The Experimental group will be given the Baseline treatment comprising of Stretching \& Static balance training (i.e. heel and toe raises, alternate rising of the left and right foot above the floor and tandem standing.) alongside Dynamic Balance training which will include (weight shifting forward, backward, sideward, and diagonally with eyes opened and eyes closed, walking toe-to-heel barefoot, side walking, reverse walking and one-foot jumps), and Progressive activity training (such as stepping over/on obstacles, throwing and catching a ball, and kicking a ball.) for 40 minutes per day, twice each week for 8 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Static balance training
Description: The Control group will continue their regular school schedule, which will include participation in physical education activities at the same frequency. Along with that Baseline treatment including Static balance training (i.e. alternate rising of the left and right foot above the floor and tandem standing.) only, at the same intervals and for the same length of time as the intervention group, with the exception of additional Dynamic balance training and progressive activity training.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Static balance training
Description: The Control group will continue their regular school schedule, which will include participation in physical education activities at the same frequency. Along with that Baseline treatment including Static balance training (i.e. alternate rising of the left and right foot above the floor and tandem standing.) only, at the same intervals and for the same length of time as the intervention group, with the exception of additional Dynamic balance training and progressive activity training.
Study: NCT06125106

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Blinatumomab
Description: Haploidentical hematopoietic stem cell transplantation was performed using a Conditioning regimen containing Blinatumomab. 28ug of Blinatumomab was administered intravenously once a day for a total of 7 days, followed by a routine conditioning regimen and haploid hematopoietic stem cell transplantation.
Study: NCT05153551

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Play-based assessment (RITA-T)
Description: The RITA-T is a play-based assessment that involves nine different activities that can be done safely with a child seated in the exam room. After scoring the RITA-T, the PEARS PCP will immediately provide feedback to the parent regarding results and next steps.~In addition, parents will complete certain assessments/surveys during the study to evaluate the program.
Study: NCT03909477

Intervention type: DIAGNOSTIC_TEST
Intervention: Hyperpolarized Xenon-129 MRI of the lungs
Description: Participants will be imaged using MRI using hyperpolarized xenon-129 gas as a contrast gas

Intervention type: DIAGNOSTIC_TEST
Intervention: Computed Tomography (CT)
Description: Participants will undergo a CT scan of the thoracic cavity

Intervention type: DIAGNOSTIC_TEST
Intervention: Pulmonary Function Tests (PFTs)
Description: Participants will have their lung function evaluated using PFTs

Intervention type: DIAGNOSTIC_TEST
Intervention: Six Minute Walk Test (6MWT)
Description: Participants \>35 years of age will perform the six minute walk test as a measure of exercise capacity

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiopulmonary exercise testing (CPET)
Description: Participants \<35 will perform cardiopulmonary exercise testing as a measure of exercise capacity

Intervention type: DIAGNOSTIC_TEST
Intervention: Sputum analysis
Description: Participants will provide a sputum sample that will be analysed for eosinophils

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood analysis
Description: Participants will have their blood drawn and analysed for eosinophil count.
Study: NCT05538455

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PC4L solutions
Description: Two different versions of the PC4L system will be tested. A fully equipped version and a cloud-based system that requires only a smartphone and a wearable sensor (Fitbit Versa 2). 25% of participants will use the full system, the remaining 75% will use the cloud-based system. As part of the decision support system, the PC4L platform includes a recommendation component. This component collects information from different sources available (directly from sensors, cognitive games, questionnaires, and the multimodal fusion engine), and under clinical and professional guidance, after evaluating the potential improvement or worsening of patients' conditions, issues personalized recommendations to address identified problems. The recommendations relate to the following areas: physical activities; sleep; cognitive; nutrition. These recommendations will generally be sent to the PC4L application on the patients' smartphone, where they will appear as pop-up notifications.
Study: NCT05790096

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Granulokine
Description: Granulokine is presented in boxes containing vials containing 1,0 mL of solution for injection and 300µg of filgrastim.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Filgrastine
Description: Filgrastine is presented in boxes containing vials containing 1,0 mL of solution for injection and 300µg of filgrastim.
Study: NCT06225882

Intervention type: DRUG
Intervention: Oxaluria evolution.
Description: To collect real data from the specific French experience by collecting data from patients treated throughout the country and to monitor in particular the evolution of oxaluria before and after treatment.
Study: NCT05512130

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Description: Participants will take empagliflozin daily for 2 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Description: Participants will take empagliflozin daily for 2 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will take a placebo daily for 2 weeks. The placebo will be identical to empagliflozin in appearance.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will take a placebo daily for 2 weeks. The placebo will be identical to empagliflozin in appearance.
Study: NCT05039606

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nedaplatin
Description: Nedaplatin is a second-generation platinum-like derivative, which is a cell cycle non-specific drug, with a mechanism of action and efficacy similar to cisplatin, and a wide anti-cancer spectrum

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Cisplatin, aka cis-dichlorodiamineplatin, is a platinum-containing anticancer drug
Study: NCT05145075

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey
Description: Patients are asked to fill in a survey concerning teleconsultations
Study: NCT05027529

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CytoSorb
Description: An extracorporeal cytokine hemoadsorption system is integrated in the VA-ECMO circuit

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: VA-ECMO only
Description: only VA-ECMO; NO extracorporeal cytokine hemoadsorption system is added
Study: NCT04274166

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: secukinumab 150 mg (2 injections per dose
Description: secukinumab 150 mg (2 injections per dose
Study: NCT05870241

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ga-As Laser
Description: Patient sits on a chair with back support and the two GA-AS laser ( 5 milli Watts \& 904 nm) probe will be applied one on the shoulder tip for 5 minutes and the other application another 5 minutes will be on the center of deltoid muscle. The main power of the laser switch will be turned on. The duration of the treatment will be 10 minutes.
Study: NCT04824352

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: apatinib
Description: Apatinib: 500 mg QD po (BSA ≥ 1.0) or 250 mg QD po (BSA \< 1.0); IE: ifosfamide 1.8 g/m2/d d1-3; etoposide 100 mg/m2/d d1-3 Q2w
Study: NCT05115266

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Animal-assisted therapy (AAT
Description: The activity program consists of 10 sessions with a duration of about 60 minutes. During the 10 sessions the animal is presented, in this case a dog. They caress it, dress it, educate it ...

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual treatment
Description: receive usual treatment (group activities)
Study: NCT05039515

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IPN60130
Description: Immediate-release capsule containing high dose of the drug substance.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IPN60130
Description: Immediate-release capsule containing low dose of the drug substance.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be supplied as powder filled hard capsules
Study: NCT05870241

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Microcurrent Electrical Stimulation
Description: The patient sits on a chair with back support and the two electrodes from Microcurrent 850 unit device will be applied one on the shoulder tip and the other electrode on the center of the deltoid muscle. A wet cloth was placed between the electrode and the patient's skin. An adhesive tape was used to hold the electrode over the treated areas. The main power switch will be turned on. The treatment duration will be for 10 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traditional therapy
Description: the patients will receive traditional physical therapy in the form of manual lymphatic drainage , compression bandage, exercise to increase lymphatic drainage, skin care. and ROM exercises to improve shoulder mobility

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traditional therapy
Description: the patients will receive traditional physical therapy in the form of manual lymphatic drainage , compression bandage, exercise to increase lymphatic drainage, skin care. and ROM exercises to improve shoulder mobility

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional therapy
Description: the patients will receive traditional physical therapy in the form of manual lymphatic drainage , compression bandage, exercise to increase lymphatic drainage, skin care. and ROM exercises to improve shoulder mobility
Study: NCT05516004

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PXL Platinum 330 system
Description: to determine the efficacy of riboflavin solution and UV light to treat cornea thinning conditions
Study: NCT05936671

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: EEG-and-ANI-guided anesthesia
Description: During anesthetic maintenance, sevoflurane concentration will be titrated according to EEG monitoring. Sevoflurane concentration will be titrated to maintain intraoperative Patient state index (PSi) ≥ 35 and to avoid burst suppression. Intraoperative target-controlled infusion of remifentanil will be titrated to maintain intraoperative ANI between 50 and 70.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: standard anesthesia
Description: During anesthetic maintenance, the attending anesthesiologists will provide a routine standard care for anesthetic and analgesic titration. In brief, hemodynamic variables and clinical situations will be used to titrate the sevoflurane concentration and remifentanil infusion rates.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane and remifentanil
Description: For anesthetic maintenance, balanced anesthesia with sevoflurane inhalation and target controlled infusion of remifentanil will be performed.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane and remifentanil
Description: For anesthetic maintenance, balanced anesthesia with sevoflurane inhalation and target controlled infusion of remifentanil will be performed.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EEG and ANI
Description: EEG monitoring using SEDline (Masimo, Irvine, California, USA) and Analgesia Nociception Index (ANI; MetroDoloris Medical Systems, Lille, France) monitoring will be performed.
Study: NCT06552884

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: (Maternity Identity Development Training)
Description: Monitoring the Effect of the Education Given to Parents According to Maternal Role Ability Theory on Maternal Role Mother-Baby and Father-Infant Attachment
Study: NCT06465680

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intern Health Study behavioral change mobile notification
Description: The study's mobile app will be used to deliver push notifications. The notifications appear on the participant's phone lock screen. The notifications include 3 categories: mood notifications, activity notifications, sleep notifications. Mood notifications aim to increase the participant's mood. Activity notifications aim to increase the participant's physical activity. Sleep notifications aim to increase the participant's sleep duration. All notifications are categorized as one of five therapeutic approaches: 1) CBT-Behavioral, 2) CBT-Cognitive, 3) Distanced Self-Talk, 4) Mindfulness, 5) Motivational Interviewing.
Study: NCT04989725

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard arm
Description: Patients on the standard arm will be treated as per standard of care in our institution. Treatment options could include switching to next systemic therapy line, best supportive care or continuing on current systemic therapy.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Experimental arm
Description: SABR to all oligoprogressive lesions + continuation of current systemic therapy
Study: NCT05257798

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IFN-β inhibitor treatment
Description: PF-06823859 (IFN-β inhibitor) 100 mg/mL solution for injection

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for PF-06823859, 0 mg/mL solution for injection
Study: NCT04809090

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SMT
Description: Standard 8 SMT (Stress Management Training) psychological interviews.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMT
Description: Standard 8 SMT (Stress Management Training) psychological interviews.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: App CA
Description: An APP together a CA (Conversational Agent).

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: App CA
Description: An APP together a CA (Conversational Agent).
Study: NCT06070324

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Breast surgery
Description: Any surgery involving incisions made along the nipple areolar complex. These would include transgender mastectomy, cisgender female breast reduction/augmentation/reconstruction, and cisgender male gynecomastia correction.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Breast surgery
Description: Any surgery involving incisions made along the nipple areolar complex. These would include transgender mastectomy, cisgender female breast reduction/augmentation/reconstruction, and cisgender male gynecomastia correction.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Breast surgery
Description: Any surgery involving incisions made along the nipple areolar complex. These would include transgender mastectomy, cisgender female breast reduction/augmentation/reconstruction, and cisgender male gynecomastia correction.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Suturing of surgical incision
Description: The closing of a surgical incision by using sutures so appose and maintain apposition of two skin edges. Suturing may or may not require knot-tying depending on the material of suture used.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Suturing of surgical incision
Description: The closing of a surgical incision by using sutures so appose and maintain apposition of two skin edges. Suturing may or may not require knot-tying depending on the material of suture used.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Suturing of surgical incision
Description: The closing of a surgical incision by using sutures so appose and maintain apposition of two skin edges. Suturing may or may not require knot-tying depending on the material of suture used.
Study: NCT06513559

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Anatomic total shoulder replacement
Description: Humeral head with a metal ball and the glenoid socket with a polyethylene glenoid component.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Reverse total shoulder replacement
Description: Polyethylene socket on the humeral side and the glenosphere going on the glenoid side.
Study: NCT06237751

Intervention type: DRUG
Group type: OTHER
Intervention: Sildenafil 100 MG
Description: Sildenafil 100mg orally half an hour before surgery
Study: NCT06404710

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants in this group will be given a gradual muscle relaxation exercise.
Study: NCT04880694

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STC3141
Description: To receive continuous infusion of STC3141 at rate 58.3mg/hr up to 3 days (72hours).~Also to receive appropriate standard of care.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STC3141
Description: To receive continuous infusion of STC3141 at rate 87.5mg/hr up to 3 days (72hours).~Also to receive appropriate standard of care.
Study: NCT05857371

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: lipoaspiration
Description: The surgeon will perform lipoaspiration under local anesthesia for the ADSVF production.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lipoaspiration
Description: The surgeon will perform lipoaspiration under local anesthesia for the ADSVF production.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: urethrotomy
Description: The urologist will perform an endoscopic urethrotomy (standard care).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: urethrotomy
Description: The urologist will perform an endoscopic urethrotomy (standard care).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: autologous ADSVF administration
Description: ADSVF will be administrated in fibrotic lesion during urethrotomy by the urologist.
Study: NCT04940117

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Eefooton oral solution
Description: Check eGFR value, liver and kidney function every month
Study: NCT05304546

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Solution for IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Encorafenib
Description: Oral QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Binimetinib
Description: Oral BID
Study: NCT05774119

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: breakfast with coffee
Description: breakfast with coffee with 6 mg/caffeine/kg body weight

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: breakfast with water
Description: breakfast with 250 mL of water